Ginkgo Bioworks Holdings, Inc.
NYSE DNA
Ginkgo Bioworks Holdings, Inc. Dividend Per Share for the Trailing 12 Months (TTM) ending September 30, 2024
Ginkgo Bioworks Holdings, Inc. Dividend Per Share is NA for the Trailing 12 Months (TTM) ending September 30, 2024. Dividend per share represents the dividends distributed per share. Indicates dividend yield potential on a per-share basis.
-
Ginkgo Bioworks Holdings, Inc. Dividend Per Share for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -0.00, a -100.00% change year over year.
-
Ginkgo Bioworks Holdings, Inc. Dividend Per Share for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 0.02, a 0.00% change year over year.
-
Ginkgo Bioworks Holdings, Inc. Dividend Per Share for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -0.00.
Key data
| Date | Dividend Per Share | Free Cash Flow Per Share | Return on Assets (ROA) | Return on Equity (ROE) |
|---|
Market news
Loading...
NYSE: DNA
| CEO | Dr. Jason Kelly Ph.D. |
| IPO Date | April 19, 2021 |
| Location | United States |
| Headquarters | 27 Drydock Avenue |
| Employees | 1,218 |
| Sector | Health Care |
| Industries | |
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email